Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor

Discovery and Development of Therapeutic Aptamers

(2010) P.R. Bouchard et al.   Annual Review of Pharmacology and Toxicology

Functional characteristics of N8, a new recombinant FVIII

(2010) M. L. S. CHRISTIANSEN et al.   HAEMOPHILIA

Aptamers as therapeutics

(2010) Anthony D. Keefe et al.   NATURE REVIEWS DRUG DISCOVERY

Thrombin generation testing in haemophilia comprehensive care centres

(2009) Y. DARGAUD et al.   HAEMOPHILIA

Thromboelastography reflects global hemostatic variation among severe haemophilia A dogs at rest and following acute exercise

(2009) M. OTHMAN et al.   HAEMOPHILIA

rFVIIa and a new enhanced rFVIIa-analogue, NN1731, reduce bleeding in clopidogrel-treated and in thrombocytopenic rats

(2009) B. LAURITZEN et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Thromboelastography in children with coagulation factor deficiencies

(2008) Meera Chitlur et al.   BRITISH JOURNAL OF HAEMATOLOGY

Thrombin generation assay: a useful routine check-up tool in the management of patients with haemophilia?

(2008) G. L. SALVAGNO et al.   HAEMOPHILIA

The Haemostatic Role of Tissue Factor Pathway Inhibitor

(2007) James T.B. Crawley et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A

(2007) S. Prasad et al.   BLOOD